Evidence map›Paper›PMID 21537355›Full record

ReviewNature reviews. Neurology2011

Depression and risk of developing dementia.

Amy L Byers, Kristine Yaffe

2 registry-linked trialsOpen access · greenAbstract readReview
In one paragraph

Review in Nature reviews. Neurology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 591 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
591citing papers in PubMed, 5 pooled it
22.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04179006 naunknown statusnot on this mapstarted 2019, after this paper: background citation

Effects of Nutrients Supplementation in Antidepressant Treated Depressive Disorder Patients

TypeinterventionalSponsorNational Cheng-Kung University HospitalRan2019 to 2023Enrolled120ConditionsDepressive Disorder, MajorArmsLF/Erinacine A-enriched Hericium/Plain chocolate + antidepressant(s)
NCT06914284 recruitingnot on this mapstarted 2024, after this paper: background citation

Apathy-related Neurobehavioral Markers of Cognitive Decline in Old-age Bipolar Disorders: Proof-of-concept

TypeobservationalSponsorHospital Center Guillaume RégnierRan2024 to 2029Enrolled30ConditionsApathy, Bipolar DisorderArmsActigraphy and MRI
3 · Its place in the literature

Who cites it

591 citing papers in PubMed, 5 syntheses or guidelines pooled it, 1,225 citations in OpenAlex.

  1. Pooled it
  2. A Systematic Review of Antidepressants and Psychotherapy Commonly Used in the Treatment of Late Life Depression for Their Effects on Cognition.The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry · 2025
    Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Psilocybin therapy for mood dysfunction in Parkinson's disease: an open-label pilot trial.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2025
    Trial
  7. Trial
  8. Depression and anxiety in vascular dementia: an update.Journal of neural transmission (Vienna, Austria : 1996) · 2026
    Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. A modifiable driver of dementia: cognitive impairment in primary aldosteronism.Hypertension research : official journal of the Japanese Society of Hypertension · 2026
    Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article

531 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Amy L ByersDepartment of Psychiatry, University of California, San Francisco and San Francisco Veterans Affairs Medical Center, 4150 Clement Street (116H), San Francisco, CA 94121, USA. amy.byers@ucsf.edu
Kristine Yaffe
San Francisco VA Medical Center · USUniversity of California, San Francisco · US

Funding

Predictors & Outcomes of Cognitive Trajectories in the Oldest OldK24AG031155 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI YAFFE, KRISTINE · 2007 to 2020
$1.5M
Long Term Depressive Symptom Course & Adverse Health Outcomes among Older WomenR01MH086498 · NIMH · NORTHERN CALIFORNIA INSTITUTE/RES/EDU · PI YAFFE, KRISTINE · 2010 to 2012
$1.0M
The Complexity of Late Life Depression: Bridging Methods and Clinical SubstanceK01MH079093 · NIMH · WEILL MEDICAL COLL OF CORNELL UNIV · PI BYERS, AMY LYNN · 2007 to 2011
$567k
NIA NIH HHS K24 AG031155NIMH NIH HHS K01 MH079093NIMH NIH HHS R01 MH086498
6 · The paper itself

Abstract

Depression is highly common throughout the life course and dementia is common in late life. Depression has been linked with dementia, and growing evidence implies that the timing of depression may be important in defining the nature of this association. In particular, earlier-life depression (or depressive symptoms) has consistently been associated with a more than twofold increase in dementia risk. By contrast, studies of late-life depression and dementia risk have been conflicting; most support an association, yet the nature of this association (for example, if depression is a prodrome or consequence of, or risk factor for dementia) remains unclear. The likely biological mechanisms linking depression to dementia include vascular disease, alterations in glucocorticoid steroid levels and hippocampal atrophy, increased deposition of amyloid-β plaques, inflammatory changes, and deficits of nerve growth factors. Treatment strategies for depression could interfere with these pathways and alter the risk of dementia. Given the projected increase in dementia incidence in the coming decades, understanding whether treatment for depression alone, or combined with other regimens, improves cognition is of critical importance. In this Review, we summarize and analyze current evidence linking late-life and earlier-life depression and dementia, and discuss the primary underlying mechanisms and implications for treatment.

Indexed as

AdultAgedDementiaDepressionHippocampusHumansHydrocortisoneInflammationMiddle AgedNerve Growth FactorsPlaque, AmyloidRiskRisk FactorsVascular DiseasesHydrocortisoneNerve Growth Factors

Identifiers

PMID21537355
PMCPMC3327554
OpenAlexW2076143792

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.